Oligodendrocyte progenitor cell migration

Oligodendrocyte progenitor cell (OPC) migration is a fundamental biological process in the central nervous system where precursor cells travel from their germinal origins to axonal targets to initiate myelination [PubMed: 30202275]. This movement is orchestrated by a complex array of chemotactic factors, including growth factors like PDGF-AA and chemokines such as CXCL12, which interact with their respective receptors on the OPC surface [PubMed: 24906100]. In pathological conditions like multiple sclerosis, the failure of OPCs to migrate effectively into inflammatory lesions prevents the subsequent remyelination of axons, leading to permanent neurological damage [PubMed: 28987358]. Therapeutic strategies currently under investigation aim to enhance this migration by inhibiting intrinsic barriers, such as LINGO-1, or by using small molecules like clemastine to stimulate pro-myelinating pathways [PubMed: 29017915, PubMed: 26362831]. Because this entry describes a multi-step cellular event rather than a single molecular entity, it is classified as a biological process rather than a discrete therapeutic target molecule.

Other names

OPC migrationOligodendrocyte precursor cell migrationMigration of oligodendrocyte progenitor cells

Pharmacological agents modulate this process by targeting specific molecular regulators such as muscarinic receptors, LINGO-1, or GPR17, which either release the 'brakes' on cell movement or provide stimulatory signals to promote the recruitment of precursor cells to demyelinated axons [PubMed: 29017915, PubMed: 26362831].